These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11742710)

  • 1. Role of erythropoietin in the treatment of lung cancer associated anaemia.
    Scagliotti GV; Novello S
    Lung Cancer; 2001 Dec; 34 Suppl 4():S91-4. PubMed ID: 11742710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
    Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
    Cheer SM; Wagstaff AJ
    Drugs; 2004; 64(3):323-46. PubMed ID: 14871172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
    Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin for patients with malignant disease.
    Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennet C; Engert A
    Cochrane Database Syst Rev; 2004; (3):CD003407. PubMed ID: 15266483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of erythropoietin in cancer-related anaemia: a double-edged sword?
    Guan X; Chen L
    J Int Med Res; 2008; 36(1):1-8. PubMed ID: 18230261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF
    Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
    Henry DH
    Drugs; 2007; 67(2):175-94. PubMed ID: 17284083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
    Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
    Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel uses for recombinant erythropoietin therapy in unlicensed indications.
    Macartney CA; Adgey AA; Jones FG; Morris TC; McMullin MF
    Hematol J; 2004; 5(2):181-5. PubMed ID: 15048070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin or darbepoetin for patients with cancer.
    Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Brunskill S; Djulbegovic B; Benett CL; Langensiepen S; Hyde C; Engert E
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003407. PubMed ID: 16856007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoetins and [symbol: see text] darbepoetin alfa in malignant disease.
    Drug Ther Bull; 2004 Mar; 42(3):21-3. PubMed ID: 15038080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline.
    Vansteenkiste J; Tomita D; Rossi G; Pirker R
    Support Care Cancer; 2004 Apr; 12(4):253-62. PubMed ID: 14740283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.
    Demetri GD
    Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):31-7. PubMed ID: 11308272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.
    Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S
    Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management options for cancer therapy-related anaemia.
    Littlewood TJ
    Drug Saf; 2002; 25(7):525-35. PubMed ID: 12093310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epoetin beta for the treatment of chemotherapy-induced anaemia in solid and haematological malignancies. Results of an open-label, multicentric clinical trial].
    Spaëth D
    Bull Cancer; 2010 Aug; 97(8):969-78. PubMed ID: 20538545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.
    Beguin Y
    Drug Saf; 1998 Oct; 19(4):269-82. PubMed ID: 9804442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical value of erythropoietin in patients with cancer.
    Dührsen U
    Drugs; 2002; 62(14):2013-23. PubMed ID: 12269847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.